0001179110-20-004405.txt : 20200402 0001179110-20-004405.hdr.sgml : 20200402 20200402075136 ACCESSION NUMBER: 0001179110-20-004405 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200331 FILED AS OF DATE: 20200402 DATE AS OF CHANGE: 20200402 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MITCHELL DEAN J CENTRAL INDEX KEY: 0001199297 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17999 FILM NUMBER: 20767383 MAIL ADDRESS: STREET 1: C/O BRISTOL MYERS SQUIBB CO STREET 2: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10164 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ImmunoGen, Inc. CENTRAL INDEX KEY: 0000855654 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 042726691 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 830 WINTER ST CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: (781)895-0600 MAIL ADDRESS: STREET 1: 830 WINTER ST CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOGEN INC DATE OF NAME CHANGE: 19920703 4 1 edgar.xml FORM 4 - X0306 4 2020-03-31 0 0000855654 ImmunoGen, Inc. IMGN 0001199297 MITCHELL DEAN J 45 HODGE ROAD PRINCETON NJ 08540 1 0 0 0 Deferred Share Unit 0 2020-03-31 4 A 0 3958 0 A 2020-03-31 Common Stock 3958 66331 D The deferred share units were issued pursuant to the Issuer's Compensation Policy for Non-Employee Directors and are convertible into Common Stock on a one-to-one basis. The vested deferred share units are to be settled 100% in shares of Common Stock of the Company upon the reporting person's retirement from the Board of Directors. The deferred share units vest upon issuance. /s/ David G. Foster, attorney in fact 2020-04-02